Ray Dalio's position in Edwards Lifesciences is currently worth $75 Million. That's 0.40% of their equity portfolio (56th largest holding). The first Edwards Lifesciences trade was made in Q3 2009. Since then Ray Dalio bought shares nineteen more times and sold shares on thirteen occasions. The investor's estimated purchase price is $88.1 Million, resulting in a loss of 15%.